CDIO
NASDAQ · Biotechnology
Cardio Diagnostics Holdings
$1.29
+0.24 (+22.86%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 758.5K | 743.9K | 754.7K |
| Net Income | -209,998 | -203,473 | -219,048 |
| EPS | — | — | — |
| Profit Margin | -27.7% | -27.4% | -29.0% |
| Rev Growth | -7.2% | +1.3% | +15.3% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 1.13M | 951.2K | 921.9K |
| Total Equity | 1.55M | 1.63M | 1.54M |
| D/E Ratio | 0.72 | 0.58 | 0.60 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | -263,366 | -243,311 | -249,018 |
| Free Cash Flow | -217,938 | -231,433 | -197,267 |